Introduction:
The oncology market in Ireland is rapidly growing, driven by advancements in medical technology and an increasing focus on cancer research and treatment. In 2021, the oncology market in Ireland was valued at €1.5 billion, with an annual growth rate of 8%. This growth is expected to continue over the next few years, with new companies emerging as key players in the market.
Top 10 Oncology Companies in Ireland 2026:
1. Pfizer Ireland Pharmaceuticals
Pfizer Ireland Pharmaceuticals is a leading oncology company in Ireland, with a market share of 15%. The company specializes in developing innovative cancer treatments and has a strong presence in the Irish market.
2. Roche Ireland
Roche Ireland is another key player in the Irish oncology market, with a market share of 12%. The company’s portfolio includes a range of cancer drugs and treatments, making it a top choice for healthcare professionals and patients alike.
3. Novartis Ireland
Novartis Ireland is known for its cutting-edge research and development in the field of oncology. With a market share of 10%, the company is a major contributor to the growth of the oncology market in Ireland.
4. AstraZeneca Ireland
AstraZeneca Ireland is a global pharmaceutical company with a strong presence in the Irish oncology market. The company’s innovative cancer treatments have made it a top choice for healthcare providers and patients, with a market share of 8%.
5. Merck Sharp & Dohme Ireland
Merck Sharp & Dohme Ireland is a key player in the Irish oncology market, with a market share of 7%. The company’s focus on research and development has led to the creation of cutting-edge cancer treatments that have had a significant impact on patient outcomes.
6. Bristol-Myers Squibb Ireland
Bristol-Myers Squibb Ireland is known for its commitment to developing effective cancer treatments. With a market share of 6%, the company is a key player in the Irish oncology market and continues to drive innovation in the field.
7. AbbVie Ireland
AbbVie Ireland is a leading oncology company in Ireland, with a market share of 5%. The company’s focus on precision medicine and personalized treatment options has made it a top choice for healthcare providers and patients.
8. Johnson & Johnson Ireland
Johnson & Johnson Ireland is a global healthcare company with a strong presence in the Irish oncology market. With a market share of 4%, the company is known for its innovative cancer treatments and commitment to improving patient outcomes.
9. Teva Pharmaceuticals Ireland
Teva Pharmaceuticals Ireland is a key player in the Irish oncology market, with a market share of 3%. The company’s focus on developing affordable cancer treatments has made it a popular choice for healthcare providers and patients in Ireland.
10. Takeda Ireland
Takeda Ireland is a leading pharmaceutical company with a market share of 2% in the Irish oncology market. The company’s portfolio includes a range of cancer treatments that have had a significant impact on patient outcomes.
Insights:
The oncology market in Ireland is expected to continue its growth trajectory over the next few years, driven by increasing investments in cancer research and treatment. By 2026, the market is projected to reach €2 billion, with a compound annual growth rate of 10%. This growth presents opportunities for both established companies and new players to make a significant impact in the Irish oncology market. As advancements in medical technology continue to drive innovation in cancer treatments, companies that focus on research and development are likely to emerge as key players in the market.
Related Analysis: View Previous Industry Report
